Assessing feasibility of the Human Theater Project to document patient experience in the NYU Perlmutter Cancer Center: A Pilot Study

Brief description of study

This is a single institution, single arm feasibility study of a first person photographic narrative program called The Human Theater Project in an outpatient cancer center. The study will enroll 20 patients with any malignancy undergoing intravenous chemotherapy at the NYU Perlmutter Cancer Center. Expected accrual is 10 patients a month and anticipated time to target accrual is 2 months. Patients will be followed for up to 3 months from time of enrollment such that expected study duration from trial initiation to completion of follow-up on all participants is expected to be 5 months.


Clinical Study Identifier: s17-00635
ClinicalTrials.gov Identifier: NCTs17-00635


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.